Insurtech startup marketing epigenetic tests that allows insurers to better estimate life expectancy, refine key underwriting factors, and improve customers’ health

ENABLING TECHNOLOGY: New saliva-based epigenetic tests predict all-cause mortality, tobacco, and alcohol usage better and less expensively than current approaches. Test value is already greater than costs, and costs will decrease dramatically.